Actively Recruiting
Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines
Led by Wake Forest University Health Sciences · Updated on 2026-01-22
100
Participants Needed
1
Research Sites
76 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this research study is to find out if using magnesium in addition to prochlorperazine will help reduce your migraine pain.
CONDITIONS
Official Title
Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 218 years or older
- Able to provide informed consent
- English speaking
- Primary diagnosis of migraine with typical migraine features (e.g., recurrent, unilateral, pounding or throbbing headache, associated with nausea) confirmed clinically
You will not qualify if you...
- Pregnancy confirmed by positive urine HCG
- Allergy or sensitivity to study drugs
- History of renal insufficiency
- History of myasthenia gravis
- Use of study drug within 48 hours prior to enrollment
- Previous participation in this trial during a different encounter
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Advocate Christ Medical Center Emergency Department
Oak Lawn, Illinois, United States, 60453
Actively Recruiting
Research Team
R
Ryan McKillip, MD
CONTACT
M
Marc McDowell, PharmD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here